Search
Subscribe for $1
Home
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Great Place To Work
Analytics
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
Home
Latest
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Rankings
Great Place To Work
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
home
home
Pharmaceutical Industry
Pharmaceutical Industry
Commentary
TrumpRx is here and it helps, though a bit less than advertised
By
Jeffrey Sonnenfeld
,
Stephen Henriques
,
Ferron Chen
,
Asuka Koda
and
Vanessa McLennan
February 11, 2026
Commentary
Sanofi CEO: The enterprise AI shift will reshape pharma in 2026
By
Paul Hudson
February 10, 2026
North America
Hims & Hers scraps copycat Wegovy weight-loss pill after probe
By
Jessica Nix
,
Madison Muller
and
Bloomberg
February 7, 2026
C-Suite
How Pfizer’s CEO wielded moral clarity to help his team do the impossible
By
Ruth Umoh
February 2, 2026
Success
Pfizer CEO Albert Bourla’s best leadership advice: Being optimistic is better than being right
By
Preston Fore
January 31, 2026
C-Suite
‘We’ll save the world from cancer’: Inside Pfizer CEO’s $23 billion post‑COVID bet on oncology
By
Nick Lichtenberg
January 30, 2026
Health
As billionaires chase immortality, this startup cofounded by a Harvard genetics professor gets FDA approval for the first partial de-aging human trial
By
Marco Quiroz-Gutierrez
January 30, 2026
Workplace Culture
Walmart doubles down on health, promoting 3,000 pharmacy workers and upping earning potential—with no college degree required
By
Sydney Lake
January 29, 2026
C-Suite
Pfizer CEO on how he struck a deal with President Trump in 10 days to lower American drug costs
By
Fortune Editors
January 27, 2026
Investing
Inside Big Pharma and VC’s big bet on AI: You wouldn’t ‘want to fly an airplane designed by hand, but all of our drugs are designed like that’
By
Nick Lichtenberg
January 23, 2026
AI
AI drug startup Insilico Medicine launches an AI ‘gym’ to help models like GPT and Qwen be good at science
By
Nicholas Gordon
January 22, 2026
Economy
Trump says Europe does one thing right: drug prices. ‘A pill that costs $10 in London costs $130 in New York or Los Angeles’
By
Sasha Rogelberg
January 21, 2026
AI
Anthropic unveils Claude for Healthcare, expands life science features, and partners with HealthEx to let users connect medical records
By
Jeremy Kahn
January 11, 2026
Economy
Mark Cuban on the $38 trillion national debt and the absurdity of U.S. healthcare: we wouldn’t pay for potato chips like this
By
Nick Lichtenberg
January 6, 2026
Health
GLP-1s could end up being ‘the first true longevity drug’ as the world battles a rising obesity crisis
By
Angelica Ang
November 21, 2025
Most Popular
Innovation
An MIT roboticist who cofounded bankrupt robot vacuum maker iRobot says Elon Musk’s vision of humanoid robot assistants...
By
Marco Quiroz-Gutierrez
Success
Jeff Bezos says being lazy, not working hard, is the root of anxiety: ‘The stress goes away the second I take that...
By
Sydney Lake
Commentary
'The Pitt': a masterclass display of DEI in action
By
Robert Raben